Adi Mor George - 29 May 2026 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 Jun 2026, 07:33:22 UTC
Prior SEC filing
10 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Adi Mor George

Key filing fact

Adi Mor George filed Form 4 for Chemomab Therapeutics Ltd. (CMMB) on 01 Jun 2026.

Key facts

  • This page summarizes Adi Mor George's Form 4 filing for Chemomab Therapeutics Ltd. (CMMB).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 01 Jun 2026, 07:33.

Change

  • Previous filing in this sequence was filed on 10 Apr 2026.
  • Current net transaction value: -$20,246.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001851069 Primary reporting owner

Mor George Adi

Relationship
Chief Executive Officer, Director
Address
C/O CHEMOMAB THERAPEUTICS LTD., 10 HABARZEL ST., BUILDING C, 10TH FLOOR, TEL AVIV, ISRAEL
Signature
/s/ Adi Mor George
Signature date
01 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CMMB transaction

American Depositary Shares

Purchase

Transaction value
$10,000
Shares
-4,878
Change %
-3.5%
Price
$2.05
Shares after
134,205
Date
29 May 2026
Ownership
Direct
CMMB transaction

American Depositary Shares

Purchase

Transaction value
$10,246
Shares
-4,926
Change %
-3.4%
Price
$2.08
Shares after
139,131
Date
29 May 2026
Ownership
Direct
CMMB transaction

American Depositary Shares

Other

Transaction value
Shares
-31,712
Change %
-50%
Price
Shares after
31,712
Date
29 May 2026
Ownership
Direct
Footnotes
F1, F2
CMMB transaction

American Depositary Shares

Other

Transaction value
Shares
-18,750
Change %
-50%
Price
Shares after
18,750
Date
29 May 2026
Ownership
Direct
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Footnote F2

The American Depositary Shares reported in this row consist of restricted share units ("RSUs") that were granted to the Reporting Person by the Issuer on November 18, 2024, and vest and become exercisable according to following schedule: 25% on October 1, 2025, thereafter, in 12 equal quarterly installments of 6.25%, such that all RSUs reported in this row will be exercisable on October 1, 2028.

Footnote F3

The American Depositary Shares reported in this row consist of RSUs that were granted to the Reporting Person by the Issuer on July 1, 2025 vest and become exercisable according to following schedule: 25% on April 10, 2026, thereafter, in 12 equal quarterly installments of 6.25%, such that all RSUs reported in this row will be exercisable on April 10, 2029.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .